THRD (Third Harmonic Bio Inc.) Volume dana dhuwit perusahaan

Simbol resmi perusahaan Third Harmonic Bio (THRD)

The development dynamics of Third Harmonic Bio rely on trials of a KIT inhibitor against urticaria. Current cash reserves confirm the movement of liquid assets, where the status equals 0.27. Margin resilience is ensured by optimizing raw material supplies for research. Business efficiency is complemented by a virtual management structure, where top management loyalty is guaranteed by equity ownership in the company.

Third Harmonic Bio Inc. - Sisa dhuwit perusahaan THRD (periode 28.04.2023 - 16.08.2025)

Rincian analitis perusahaan Third Harmonic Bio

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:THRD thirdharmonicbio.com
Produk merek Third Harmonic Bio, Inc.

This indicator measures the dynamics of liquid assets, allowing for an assessment of management's financial discipline and the burn rate. Analyzing the accumulation trend helps investors determine the balance between the risk of funding shortages and capital efficiency. The dynamics of current cash reserves reflect the actual pace of operational funding. For Third Harmonic Bio (THRD), this is critical during the development of oral medications for urticaria. A sufficient cash cushion ensures the transition from injectable therapy to the mass market.

Pesaing Third Harmonic Bio

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dhuwit awis perusahaan SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Enlivex Therapeutics Ltd - Dhuwit awis perusahaan|Sisa dhuwit perusahaan QTTB|GOVX - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Edesa|IBIO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Carisma Therapeutics Inc (CARM)|Dana dhuwit perusahaan XTL Biopharmaceuticals, Ltd.|Dana dhuwit perusahaan BOLT|Dhuwit awis perusahaan HCWB (HCW Biologics, Inc.)|Gunggung dana dhuwit perusahaan APVO|AIM ImmunoTech - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ADTX|GRI - Dana dhuwit perusahaan|XRTX (XORTX Therapeutics Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|HIND: Volume dana dhuwit perusahaan|REVB (Revelation Bio) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Indaptus|Scinai Immunotherapeutics (SCNI) - Aset likuid perusahaan|Volume dana dhuwit perusahaan CALI|Dhuwit awis perusahaan Affimed NV AFMD|Dana dhuwit perusahaan Allakos Inc ALLK|HOOK (HOOKIPA) - Total volume dana dhuwit perusahaan|IGM Biosciences - Volume dana dhuwit perusahaan|ITOS - Volume dana dhuwit perusahaan|Ocean Biomedical Corp (OCEA) - Dana dhuwit perusahaan|TC BioPharm (Holdings) Plc - Sisa dhuwit perusahaan